Skip to Content
Aman Buzdar

Aman Buzdar

Associate Member


MDA 1MC12.2455 (Unit 1634)

The University of Texas MD Anderson Cancer Center
Departments of Clinical Research and Breast Medical Oncology

My research interests have been defining and improving the short- and long-term benefits of systemic adjuvant therapies for breast cancer. My colleagues and I demonstrated that fluorouracil, doxorubicin, and cyclophosphamide (FAC) chemotherapy before surgery is effective in reducing the risk of recurrence and substantially improves the odds of remaining free of disease for women with operable breast cancer.


MDACC Faculty

Education & Training

M.D. - Nishtar Medical College - 1967